
    
      Eligible subjects will receive the investigational AIOL in one eye and be followed at 1 day,
      1 week, 1 month, 3 months, 6 months, 12 months, 18 months, 24 months and 36 months
      post-operation.

      This study was designed and conducted by PowerVision, Inc. Alcon Research, LLC, acquired
      PowerVision, Inc., in 2019.
    
  